MicroRNAs: Exploring a new dimension in the pathogenesis of kidney cancer

BMC Medicine

Volumn 8, Issue , 2010, Pages

  White, Nicole M A ^a,b   Yousef, George M ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; TUMOR MARKER; VHL PROTEIN, HUMAN; VON HIPPEL LINDAU PROTEIN;

CARCINOGENESIS; CELL CYCLE REGULATION; KIDNEY CARCINOMA; NOTE; PATHOGENESIS; EDITORIAL; GENETICS; HUMAN; KIDNEY TUMOR; METABOLISM; PATHOLOGY;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; MICRORNAS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 77958043441     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-8-65     Document Type: Note

References (27)

1. Neal CS, Michael MZ, Rawlings LH, Van der Hoek MB, Gleadle JM. The VHL-dependent regulation of microRNAs in renal cell cancer. BMC Med 2010, 8:64. 10.1186/1741-7015-8-64, 20964835.
2. Turner KJ, Moore JW, Jones A, Taylor CF, Cuthbert-Heavens D, Han C, Leek RD, Gatter KC, Maxwell PH, Ratcliffe PJ, et al. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res 2002, 62:2957-2961.
3. Young AP, Schlisio S, Minamishima YA, Zhang Q, Li L, Grisanzio C, Signoretti S, Kaelin WG. VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. Nat Cell Biol 2008, 10:361-369. 10.1038/ncb1699, 18297059.
4. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610.
5. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5:522-531. 10.1038/nrg1379, 15211354.
6. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355. 10.1038/nature02871, 15372042.
7. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20. 10.1016/j.cell.2004.12.035, 15652477.
8. Chow TF, Youssef YM, lianidou E, Romaschin AD, Honey RJ, Stewart R, Pace KT, Yousef GM. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem 2009, 43:150-158. 10.1016/j.clinbiochem.2009.07.020, 19646430.
9. Schaefer A, Jung M, Kristiansen G, Lein M, Schrader M, Miller K, Stephan C, Jung K. MicroRNAs and cancer: current state and future perspectives in urologic oncology. Urol Oncol 2010, 28:4-13.
10. White NM, Bao TT, Grigull J, Youssef YM, Girgis A, Diamandis M, Fatoohi E, Metias M, Honey RJ, Stewart R, et al. MiRNA profiling in clear cell renal cell carcinoma: biomarker discovery and the identification of potential controls and consequences of miRNA dysregulation. J Path 2010, in press.
11. White NM, Fatoohi E, Metias M, Jung K, Stephan C, Yousef GM. Metastamirs: A stepping stone towards improved cancer management. Nature Rev Clin Oncol 2010, in press.
12. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007, 26:745-752. 10.1016/j.molcel.2007.05.010, 1939978, 17540599.
13. Shalgi R, Pilpel Y, Oren M. Repression of transposable-elements - a microRNA anti-cancer defense mechanism?. Trends Genet 2010, 26:253-259. 10.1016/j.tig.2010.03.006, 20417576.
14. Jung M, Mollenkopf HJ, Grimm C, Wagner I, Albrecht M, Waller T, Pilarsky C, Johannsen M, Stephan C, Lehrach H, et al. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 2009, 19:3918-3928.
15. Chow TF, Mankaruos M, Scorilas A, Youssef Y, Girgis A, Mossad S, Metias S, Rofael Y, Honey RJ, Stewart R, et al. The miR-17-92 cluster is over expressed in, and has an oncogenic effect on, renal cell carcinoma. J Urol 2010, 183:743-751. 10.1016/j.juro.2009.09.086, 20022054.
16. Chen Z, Li Y, Zhang H, Huang P, Luthra R. Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 2010, 29:4362-4368. 10.1038/onc.2010.193, 20498629.
17. Favaro E, Ramachandran A, McCormick R, Gee H, Blancher C, Crosby M, Devlin C, Blick C, Buffa F, Li JL, et al. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS ONE 2010, 5:e10345. 10.1371/journal.pone.0010345, 2859946, 20436681.
18. Gonsalves CS, Kalra VK. Hypoxia-mediated expression of 5-lipoxygenase-activating protein involves HIF-1alpha and NF-kappaB and microRNAs 135a and 199a-5p. J Immunol 2010, 184:3878-3888. 10.4049/jimmunol.0902594, 20194722.
19. Muth M, Theophile K, Hussein K, Jacobi C, Kreipe H, Bock O. Hypoxia-induced down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) m. J Transl Med 2010, 8:33. 10.1186/1479-5876-8-33, 2853517, 20356416.
20. Metias SM, lianidou E, Yousef GM. MicroRNAs in clinical oncology: at the crossroads between promises and problems. J Clin Pathol 2009, 62:771-776. 10.1136/jcp.2009.064717, 19734473.
21. Fridman E, Dotan Z, Barshack I, David MB, Dov A, Tabak S, Zion O, Benjamin S, Benjamin H, Kuker H, et al. Accurate molecular classification of renal tumors using MicroRNA expression. J Mol Diagn 2010, 12:687-696. 10.2353/jmoldx.2010.090187, 20595629.
22. Arsanious A, Bjarnason GA, Yousef GM. From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma. Mol Cancer 2009, 8:20. 10.1186/1476-4598-8-20, 2667482, 19291329.
23. Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, Teh BT. MicroRNA profiling of human kidney cancer subtypes. Int J Oncol 2009, 35:109-114. 10.3892/ijo_00000318, 19513557.
24. Seto AG. The road toward microRNA therapeutics. Int J Biochem Cell Biol 2010, 42:1298-1305. 10.1016/j.biocel.2010.03.003, 20227519.
25. Petrocca F, Lieberman J. Micromanipulating cancer: microRNA-based therapeutics?. RNA Biol 2009, 6:335-340. 10.4161/rna.6.3.9013, 19535911.
26. Wang V, Wu W. MicroRNA-based therapeutics for cancer. BioDrugs 2009, 23:15-23. 10.2165/00063030-200923010-00002, 19344188.
27. Yousef GM. microRNAs: a new frontier in kallikrein research. Biol Chem 2008, 389:689-694. 10.1515/BC.2008.068, 18627305.